Caxton Associates (New York)’s AB InBev BUD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-2,500
Closed -$252K 414
2018
Q2
$252K Hold
2,500
0.01% 325
2018
Q1
$275K Sell
2,500
-88,700
-97% -$9.84M 0.01% 295
2017
Q4
$10.2M Sell
91,200
-90,000
-50% -$10.6M 0.5% 57
2017
Q3
$21.6M Buy
181,200
+161,200
+806% +$18.9M 0.77% 19
2017
Q2
$2.21M Sell
20,000
-12,500
-38% -$1.43M 0.09% 183
2017
Q1
$3.57M Buy
+32,500
New +$3.49M 0.01% 138
2014
Q3
Sell
-25,000
Closed -$2.87M 193
2014
Q2
$2.87M Buy
+25,000
New +$2.75M 0.15% 108

Other funds holding BUD

Caxton Associates (New York)'s BUD Position: Q3 2018 in Review

Caxton Associates (New York) sold out of AB InBev (BUD) in Q3 2018, closing a stake of 2,500 shares — an estimated $252K sold.

Caxton Associates (New York) first reported a position in BUD in Q2 2014 and held it in 7 quarters. The position peaked at $21.6M in Q3 2017. 552 funds tracked by Wall St. Rank hold BUD as of Q3 2018.

  • Caxton Associates (New York) reported no remaining AB InBev position as of Q3 2018 after selling out during the quarter.
  • Caxton Associates (New York) sold 2,500 AB InBev shares in Q3 2018, an estimated $252K.
  • Caxton Associates (New York) first reported a position in AB InBev in Q2 2014 and held it in 7 quarters.
  • Caxton Associates (New York)'s AB InBev position peaked at $21.6M in Q3 2017.
  • 552 funds tracked by Wall St. Rank held AB InBev as of Q3 2018.

Based on Caxton Associates (New York)'s 13F filing for Q3 2018, filed 14 Nov 2018.